Nutrition & metabolism · Austin area, TX
Nutrition and metabolism studies in Austin area, TX
12 recruiting studies have a site in the Austin area. This page includes nearby cities such as Round Rock, Cedar Park, Georgetown, Pflugerville.
12 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated…
Eccogene
- Location
- Austin, TX + 65 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Regeneron Pharmaceuticals
- Location
- Austin, TX + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
GlaxoSmithKline
- Location
- Arlington, TX + 10 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
GlaxoSmithKline
- Location
- Arlington, TX + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Regeneron Pharmaceuticals
- Location
- Austin, TX + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Austin, TX + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
GlaxoSmithKline
- Location
- Arlington, TX + 28 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Arlington, TX + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
GlaxoSmithKline
- Location
- Austin, TX + 24 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Rivus Pharmaceuticals, Inc.
- Location
- Austin, TX + 30 other US sites
- Eligibility basics
- Ages 30+
- RecruitingHealthy volunteers
Mothers and CareGivers Investing in Children Study 2.0
University of Texas at Austin
- Location
- Austin, TX
- Eligibility basics
- Ages 0 mo–90
- RecruitingHealthy volunteers
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
University of Texas at Austin
- Location
- Austin, TX
- Eligibility basics
- Ages 30–60 · Women only
Who these studies look for
Expect limits on supplements, alcohol and diet changes during the study, and sometimes a set BMI range.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.